Skip to Main Content

Paper Details

Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals.
Journal of Infectious Diseases
6
2022
Author NameAffiliation
David C MontefioriDepartment of Surgery and Duke Human Vaccine Institute, Duke University Medical Center
  • 1 - 1

Datasets

Release 1.2